DK699788A - Heterocyclisk substituerede quinolincarboxylsyre-forbindelser og deres anvendelse til fresmtilling af antibakterielle laegemidler samt farmaceutiske praeparater indeholdende forbindelserne - Google Patents

Heterocyclisk substituerede quinolincarboxylsyre-forbindelser og deres anvendelse til fresmtilling af antibakterielle laegemidler samt farmaceutiske praeparater indeholdende forbindelserne

Info

Publication number
DK699788A
DK699788A DK699788A DK699788A DK699788A DK 699788 A DK699788 A DK 699788A DK 699788 A DK699788 A DK 699788A DK 699788 A DK699788 A DK 699788A DK 699788 A DK699788 A DK 699788A
Authority
DK
Denmark
Prior art keywords
compounds
preparation
pharmaceutical preparations
preparations containing
medicinal products
Prior art date
Application number
DK699788A
Other languages
Danish (da)
English (en)
Other versions
DK699788D0 (da
Inventor
Katherine Elizabeth Brighty
Iii John Adams Lowe
Paul Robert Mcguirk
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of DK699788D0 publication Critical patent/DK699788D0/da
Publication of DK699788A publication Critical patent/DK699788A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Quinoline Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
DK699788A 1987-12-18 1988-12-16 Heterocyclisk substituerede quinolincarboxylsyre-forbindelser og deres anvendelse til fresmtilling af antibakterielle laegemidler samt farmaceutiske praeparater indeholdende forbindelserne DK699788A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1987/003412 WO1989005643A1 (en) 1987-12-18 1987-12-18 Heterocyclic-substituted quinoline-carboxylic acids

Publications (2)

Publication Number Publication Date
DK699788D0 DK699788D0 (da) 1988-12-16
DK699788A true DK699788A (da) 1989-08-11

Family

ID=22202722

Family Applications (1)

Application Number Title Priority Date Filing Date
DK699788A DK699788A (da) 1987-12-18 1988-12-16 Heterocyclisk substituerede quinolincarboxylsyre-forbindelser og deres anvendelse til fresmtilling af antibakterielle laegemidler samt farmaceutiske praeparater indeholdende forbindelserne

Country Status (18)

Country Link
US (1) US5037834A (no)
EP (1) EP0321191B1 (no)
JP (1) JPH0725757B2 (no)
KR (1) KR900008568B1 (no)
AT (1) ATE113599T1 (no)
AU (1) AU600188B2 (no)
DE (1) DE3852010T2 (no)
DK (1) DK699788A (no)
ES (1) ES2061695T3 (no)
FI (1) FI90239C (no)
IE (1) IE65732B1 (no)
IL (1) IL88664A (no)
MY (1) MY104072A (no)
NO (1) NO178149C (no)
NZ (1) NZ227357A (no)
PT (1) PT89222B (no)
WO (1) WO1989005643A1 (no)
ZA (1) ZA889395B (no)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL83049A (en) * 1986-07-04 1991-12-12 Chemie Linz Ag 4-quinolinone-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them
EP0303291B1 (en) * 1987-08-14 1995-04-26 Asahi Glass Company Ltd. Fluorinated benzoyl compounds
US5093515A (en) * 1987-08-14 1992-03-03 Asahi Glass Company Ltd. Fluorinated benzoyl compounds
US5214051A (en) * 1989-08-01 1993-05-25 Pfizer Inc. Thiazolyl and oxazolyl[5,4-c]piperidyl-substituted quinolone-carboxylic acid and related analogs thereof having antibacterial properties are disclosed
KR910009330B1 (ko) * 1989-10-23 1991-11-11 재단법인 한국화학연구소 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
KR910009333B1 (ko) * 1989-10-23 1991-11-11 재단법인 한국화학연구소 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
DE4342186A1 (de) * 1993-12-10 1995-06-14 Bayer Ag Eintopfverfahren zur Herstellung von 3-Chinoloncarbonsäurederivaten
DE19652239A1 (de) * 1996-12-16 1998-06-18 Bayer Ag Verwendung von 7-(2-Oxa-5,8-diazabicyclo[4.3.0]non-8-yl)-chinolon- und -naphthyridoncarbonsäure-Derivaten zur Therapie von Helicobacter-pylori-Infektionen und den damit assoziierten gastroduodenalen Erkrankungen
US6608081B2 (en) 1999-08-12 2003-08-19 Ortho-Mcneil Pharmaceutical, Inc. Bicyclic heterocyclic substituted phenyl oxazolidinone antibacterials, and related compositions and methods
US6855385B2 (en) * 2000-05-31 2005-02-15 Ttm Advanced Circuits, Inc. PCB support plate for PCB via fill
AU2002256995A1 (en) * 2001-02-07 2002-08-28 Ortho-Mcneil Pharmaceutical, Inc. Pyridoarylphenyl oxazolidinone antibacterials, and related compositions and methods
BR0314759A (pt) * 2002-09-26 2005-07-26 Pfizer Derivados de pirazol
CL2004000553A1 (es) 2003-03-20 2005-02-04 Actelion Pharmaceuticals Ltd Uso de compuestos derivados de guanidina como antagonistas del receptor de neuropeptido ff; compuestos derivados de guanidina; procedimientos de preparacion; y composicion farmaceutica que los comprende.
GB0610804D0 (en) * 2006-05-31 2006-07-12 Portela & Ca Sa New crystal forms
AR062210A1 (es) * 2006-08-04 2008-10-22 Merz Pharma Gmbh & Co Kgaa Pirazolopirimidinas sustituidas, un proceso para su preparacion y su uso como medicamento
US20110053997A1 (en) * 2007-12-05 2011-03-03 Alexander Beliaev Salts and Crystal Forms
CN105712976A (zh) * 2011-08-31 2016-06-29 大塚制药株式会社 喹诺酮化合物
EP3700521B1 (en) * 2017-10-29 2024-06-12 China Medical University Use of adam9 inhibitor compound and composition including adam9 inhibitor compound

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE418966B (sv) * 1974-02-18 1981-07-06 Haessle Ab Analogiforfarande for framstellning av foreningar med magsyrasekretionsinhiberande verkan
JPS53141286A (en) * 1977-05-16 1978-12-08 Kyorin Seiyaku Kk Novel substituted quinolinecarboxylic acid
JPS5746986A (en) * 1980-09-02 1982-03-17 Dai Ichi Seiyaku Co Ltd Pyrido(1,2,3-de)(1,4)benzoxazine derivative
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
US4665079A (en) * 1984-02-17 1987-05-12 Warner-Lambert Company Antibacterial agents
JPS59128383A (ja) * 1982-12-29 1984-07-24 Kanebo Ltd 新規キノリンカルボン酸誘導体および該化合物を有効成分とする抗菌剤
JPS59204194A (ja) * 1983-05-09 1984-11-19 Hokuriku Seiyaku Co Ltd ７−ジアザビシクロアルカン置換−６，８−ジフオロ−４−オキソ−１，４−ジヒドロキノリン−３−カルボン酸誘導体
GB8333798D0 (en) * 1983-12-19 1984-01-25 Fujisawa Pharmaceutical Co Quinolone compounds
US4571396A (en) * 1984-04-16 1986-02-18 Warner-Lambert Company Antibacterial agents
US4636506A (en) * 1984-12-06 1987-01-13 Pfizer, Inc. 7-heterocyclic-1,4-dihydroquinolones
US4657913A (en) * 1985-04-18 1987-04-14 Warner-Lambert Company Trifluoro- quinoline -3- carboxylic acids and their use as anti-bacterial agents
DE3519286A1 (de) * 1985-05-30 1986-12-04 Bayer Ag, 5090 Leverkusen 7-azolyl-1-cyclopropyl-1,4-dihydro-4-oxo-3- chinolincarbonsaeuren und -1,8-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
IN166416B (no) * 1985-09-18 1990-05-05 Pfizer

Also Published As

Publication number Publication date
IE883763L (en) 1989-06-18
ES2061695T3 (es) 1994-12-16
ZA889395B (en) 1990-08-29
IE65732B1 (en) 1995-11-15
DK699788D0 (da) 1988-12-16
IL88664A (en) 1993-08-18
FI893883A0 (fi) 1989-08-17
JPH01211587A (ja) 1989-08-24
NO893305D0 (no) 1989-08-17
KR900008568B1 (ko) 1990-11-24
NO178149B (no) 1995-10-23
PT89222A (pt) 1989-12-29
FI90239B (fi) 1993-09-30
NO893305L (no) 1989-10-17
EP0321191A2 (en) 1989-06-21
WO1989005643A1 (en) 1989-06-29
PT89222B (pt) 1994-11-30
EP0321191A3 (en) 1991-02-27
US5037834A (en) 1991-08-06
AU2698788A (en) 1989-06-22
FI893883A (fi) 1989-08-17
AU600188B2 (en) 1990-08-02
EP0321191B1 (en) 1994-11-02
DE3852010T2 (de) 1995-03-09
MY104072A (en) 1993-11-30
JPH0725757B2 (ja) 1995-03-22
ATE113599T1 (de) 1994-11-15
DE3852010D1 (de) 1994-12-08
IL88664A0 (en) 1989-07-31
NZ227357A (en) 1991-04-26
KR890009925A (ko) 1989-08-04
FI90239C (fi) 1994-01-10
NO178149C (no) 1996-01-31

Similar Documents

Publication Publication Date Title
DK699788A (da) Heterocyclisk substituerede quinolincarboxylsyre-forbindelser og deres anvendelse til fresmtilling af antibakterielle laegemidler samt farmaceutiske praeparater indeholdende forbindelserne
IS3156A7 (is) Aðferð við framleiðslu á N1-súbstitúeruðum bensimidasólafleiðum til að nota við lækningar
DK407588A (da) Oxadiazolforbindelse, farmaceutisk praeparat indeholdende en saadan forbindelse, anvendelse af forbindelsen til fremstilling af et laegemiddel samt fremgangsmaade til fremstilling af en saadan forbindelse
DK92786A (da) Labdaner, fremgangsmaade til fremstilling deraf samt deres anvendelse som laegemidler
NO165545C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive nye oksadiazolimidazo-benzodiazepinderivater.
DK623888D0 (da) 9a-allyl- og propargylderivater af 9-deoxo-9a-aza-9a-homoerythromycin a, farmaceutiske praeparater indeholdende disse og deres anvendelse til fremstilling af antibakterielle laegemidler
NO883444D0 (no) Fremgangsmaate til fremstilling av nye umettede aminosyreforbindelser.
IL66776A (en) 2beta-substituted-2alpha-methyl-(5r)-penam-3alpha-carboxylic acid 1,1-dioxides,their preparation and pharmaceutical compositions containing them
NO893167L (no) Nye 6-fluor-3,5-dihydroksykarboksylsyrer og deres derivater samt fremgangsmaater for fremstilling derav.
DK166384C (da) Analogifremgangsmaade til fremstilling af (-)-15-deoxyspergualing og farmaceutisk acceptable syreadditionsssalte heraf samt mellemprodukt
DK423289D0 (da) Sulfonamider med tetrazolylrest, fremgangsmaade til deres fremstilling samt laegemiddel
NO891919D0 (no) Fremgangsmaate for fremstilling av nye karboksylsyrederivater.
ES2095831T3 (es) Acidos tetrahidro-4-fenilimino-3-tiofeno-aceticos.
ES2083961T3 (es) Acidos 3-anilino-2-hidroxicarbonil-4-tiofenoaceticos.

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment